National Institutes of Health

October 2, 2020

The role in a national trial could validate the technology as a predictor for drug therapies’ effectiveness against patients’ kidney diseases.

Biomedical researchers are struggling these days to fuel scientific pursuits. Cuts to the National Institutes of Health (NIH) budget are squeezing many investigators, particularly those early in their careers.

Subscribe to National Institutes of Health